ABIONYX Pharma SA(FR:ABNX)
€1.64-0.03 (-2.04%)
FR:ABNX
ABIONYX Pharma SA financials statements
€1.64
At close:-0.03 (-2.04%)
Want to see FR:ABNX full AI Analyst Report?
ABIONYX Pharma SA (ABNX) Income Statement
7 Followers
ABIONYX Pharma SA Income Statement
Last quarter (Q2 2026), ABIONYX Pharma SA's total revenue was €1.93M, a decrease of 17.53% from the same quarter last year. In Q2, ABIONYX Pharma SA's net income was €-4.81M. See ABIONYX Pharma SA’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| € 4.06M | € 4.60M | € 4.64M | € 5.25M | € 675.00K | |
| € 376.00K | € 844.00K | € 618.00K | € 636.00K | € 259.00K | |
| € 6.63M | € 5.31M | € 4.03M | € 4.75M | € 6.21M | |
| Depreciation and Amortization | € 551.00K | € 135.00K | € 153.00K | € 135.00K | € 119.00K |
| € -5.70M | € -5.27M | € -4.53M | € -4.01M | € -7.42M | |
| € -6.25M | € -5.57M | € -3.41M | € -4.11M | € -5.95M | |
| € 17.00K | € 84.00K | € -106.00K | € -97.00K | € 130.00K | |
| € -6.24M | € -5.47M | € -3.52M | € -4.21M | € -5.82M | |
| € -5.55M | € -4.40M | € -3.52M | € -4.21M | € -5.82M | |
| Per Share Metrics | |||||
| Basic EPS | € -0.16 | € -0.13 | € -0.12 | € -0.15 | € -0.23 |
| Diluted EPS | € -0.16 | € -0.13 | € -0.12 | € -0.15 | € -0.23 |
| Weighted Average Shares Outstanding | 35.51M | 33.70M | 29.35M | 27.97M | 24.88M |
| Weighted Average Shares Outstanding (Diluted) | 35.51M | 33.70M | 29.35M | 27.97M | 24.88M |
Currency in EUR

